AKTHELIA PHARMACEUTICALS

akthelia-pharmaceuticals-logo

Akthelia is an emerging pharmaceutical company focused on the discovery and development of novel antimicrobial therapeutics, which enhance the body‘s innate microbial defences. The ever-increasing resistance to currently marketed antibiotics has led to a clear need for novel anti-infective agents that are active against drug resistant bacteria, opportunistic infections and acute infections of unknown causes. Akthelia has a diverse pipeline of products under development, targeting microbial ... infections. The current focus is on lung and gastrointestinal infections. In close collaboration with scientists at the Karolinska Institute in Stockholm and University of Iceland, evidence of new active ingredients and modes of action is being generated. The ensuing research is feeding the product pipeline and generating new product opportunities for further development.

#SimilarOrganizations #People #Financial #Event #Website #More

AKTHELIA PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2001-12-01

Address:
Reykjavík, Gullbringusysla, Iceland

Country:
Iceland

Website Url:
http://www.aktheliapharma.com

Total Employee:
1+

Status:
Active

Contact:
(354)510-1800

Email Addresses:
[email protected]

Total Funding:
64 M ISK

Technology used in webpage:
Euro Icelandic Server Location


Similar Organizations

faron-pharmaceuticals-logo

Faron Pharmaceuticals

Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

nuchem-sciences-logo

NuChem Sciences

NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.

phasebio-pharmaceuticals-logo

PhaseBio Pharmaceuticals

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

tcr2-logo

TCR2

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.

tmunity-therapeutics-logo

Tmunity Therapeutics

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells

viatris-logo

Viatris

Viatris is a global pharmaceutical company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer.

Current Employees Featured

birgitta-agerberth_image

Birgitta Agerberth
Birgitta Agerberth Co-Founder @ Akthelia Pharmaceuticals
Co-Founder

eiríkur-steingrímsson_image

Eiríkur Steingrímsson
Eiríkur Steingrímsson Co-Founder and Board Member @ Akthelia Pharmaceuticals
Co-Founder and Board Member
2018-02-01

egill-masson_image

Egill Masson
Egill Masson CEO @ Akthelia Pharmaceuticals
CEO
2018-02-01

guðmundur-hrafn-guðmundsson_image

Guðmundur Hrafn Guðmundsson
Guðmundur Hrafn Guðmundsson Co-Founder and Chairman @ Akthelia Pharmaceuticals
Co-Founder and Chairman

Founder


birgitta-agerberth_image

Birgitta Agerberth

eiríkur-steingrímsson_image

Eiríkur Steingrímsson

guðmundur-hrafn-guðmundsson_image

Guðmundur Hrafn Guðmundsson

roger-strömberg_image

Roger Strömberg

Investors List

horizon-europe_image

Horizon Europe

Horizon Europe investment in Grant - Akthelia Pharmaceuticals

technologydevelopmentfund_image

Technology Development Fund

Technology Development Fund investment in Grant - Akthelia Pharmaceuticals

technologydevelopmentfund_image

Technology Development Fund

Technology Development Fund investment in Grant - Akthelia Pharmaceuticals

technologydevelopmentfund_image

Technology Development Fund

Technology Development Fund investment in Grant - Akthelia Pharmaceuticals

Newest Events participated

salss-science4peace_event_image Participated in SALSS Science4Peace on 2022-12-11 as speaker

Official Site Inspections

http://www.aktheliapharma.com Semrush global rank: 8.39 M Semrush visits lastest month: 539

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.107
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Akthelia Pharmaceuticals"

ABOUT - Akthelia Pharma

Akthelia was founded by four eminent professors from the Karolinska Institute in Sweden and the University of Iceland. The company is focused on the discovery and development of …See details»

Akthelia Pharmaceuticals - Crunchbase Company Profile & Funding

Akthelia is an emerging pharmaceutical company focused on the discovery and development of novel antimicrobial therapeutics, which enhance the body‘s innate microbial defences.See details»

Akthelia Pharmaceuticals - BIO International Convention 2025

Akthelia is a late preclinical state biopharma company with a unique, first-in-class immunomodulatory strategy upregulating innate immunity in epithelia.See details»

Akthelia Pharmaceuticals - Devex

Learn more about Akthelia Pharmaceuticals's jobs, projects, latest news, contact information and geographical presence. Akthelia is an preclinical stage pharmaceutical company founded by …See details»

Akthelia Company Profile - Craft

Akthelia has 5 employees across 2 locations and $507.05 k in total funding,. See insights on Akthelia including office locations, competitors, revenue, financials, executives, subsidiaries …See details»

Akthelia - Org Chart, Teams, Culture & Jobs - The Org

View Akthelia's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Akthelia Pharmaceuticals - LinkedIn

Akthelia Pharma is a late preclinical-stage immunotherapy company, with its HQ in Iceland, targeting a huge unmet opportunity to improve cancer and cell/organ transplant outcomes …See details»

Akthelia Pharmaceuticals | Leaders in Epithelial Science

Decades of research by our founding scientists, have led us to a powerful therapeutic approach that mimics and enhances the effects of natural metabolites released by microbiota to maintain …See details»

Akthelia - 2025 Company Profile & Competitors - Tracxn

Mar 22, 2025 Akthelia - Developer of small molecule therapeutic candidates for the treatment of cancer. Akthelia has 3286 competitors.See details»

Akthelia Pharmaceuticals - Products, Competitors, Financials, …

Malin Otmani April 15, 2025 According to the World Health Organization (WHO), Antimicrobial resistance (AMR) is directly responsible for an estimated 1.14 million deaths a year and …See details»

Akthelia Pharmaceuticals - Contacts, Employees, Board Members, …

Experience the new Crunchbase, powered by AI . Organization. Akthelia PharmaceuticalsSee details»

Pharmaceutical company introduced at American symposium

Apr 25, 2018 The startup company Akthelia Pharmaceuticals, founded on the basis of research conducted by scientists at the University of Iceland and the Karolinska Institute in Sweden, …See details»

PIPELINE | Akthelia Pharma

Our exciting pre-clinical stage portfolio includes our lead program - an oral prophylactic treatment for chemically induced febrile neutropenia designed to prevent life threatening infections that …See details»

Akthelia Pharmaceuticals - PitchBook

Information on valuation, funding, cap tables, investors, and executives for Akthelia Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»

Akthelia company information, funding & investors | Dealroom.co

Dec 1, 2001 Akthelia, akthelia is focused on the discovery and development of novel antimicrobial therapeutics. Here you'll find information about their funding, investors and team.See details»

PLATFORM | Akthelia Pharma

Our lead patent-protected small molecule therapeutic candidates are aroylated phenylene diamines - small molecules that mimic but enhance the natural effects of SCFAs in vivo, via …See details»

AphaiaPharma – back to balance

Feb 20, 2025 Aphaia Pharma to Participate in Panel Discussion at the 1 st Annual BioPharma Obesity Innovation Forum in San Francisco. ZUG, Switzerland, SAN JUAN, Puerto Rico and …See details»

NEWS - Akthelia Pharma

Sep 1, 2020 RANNÍS, the Icelandic technology fund, has awarded Akthelia Pharma $330,000 for the initial development of its novel wound healing approach.See details»

Akthelia Pharmaceuticals and the University of Iceland Secure a …

Apr 17, 2023 The project seeks to address antimicrobial resistance (AMR), a major global health threat identified by the World Health Organization (WHO) as one of the top 10 health …See details»

CLINICAL FOCUS - Akthelia Pharma

Akthelia is developing small molecule therapeutics that immunomodulate epithelial surfaces to counteract the pathogenesis of these diseases. Our exciting pre-clinical stage portfolio …See details»

linkstock.net © 2022. All rights reserved